Concepedia

Anna Largajolli

AL

Statistics

Publications

3

Citations

70

H-Index

3

Active since

2013

Affiliations

Certara (United States)(Current)

Anna Largajolli is an author at Certara (United States) specializing in medicine, pharmacology, and patient selection.

ORCID

Top concepts

Publications per year

2013–2022

3

Publications

3

Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women

Kristina M. Utzschneider, Anna Largajolli, Alessandra Bertoldo et al. · Journal of Diabetes and its Complications · 2013 · 30 citations · Full text

, , +12

Operating characteristics of stepwise covariate selection in pharmacometric modeling

Malidi Ahamadi, Anna Largajolli, Paul M. Diderichsen et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2019 · 27 citations

, , +4

Mobocertinib Dose Rationale in Patients with Metastatic NSCLC with <i>EGFR</i> Exon 20 Insertions: Exposure–Response Analyses of a Pivotal Phase I/II Study

Neeraj Gupta, Anna Largajolli, Han Witjes et al. · Clinical Pharmacology & Therapeutics · 2022 · 13 citations · Full text

, , +15

1–3 of 3